Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Roche launches Bluetooth coagulation testing system

New CoaguChek device can wirelessly transmit test data to a patient's clinic

Roche Bluetooth CoaguChek INRange 

Roche has expanded its range of technology-enabled testing devices with the launch of a Bluetooth coagulation system that allows patients to check how quickly their blood clots.

The company first launched its CoaguChek system in 1993 and the latest line-extension, the CoaguChek INRange, enables test data to be wirelessly transmitted to a patient's clinic following home tests, cutting down on visits to their hospital or GP.

Roland Diggelmann, COO at Roche Diagnostics, said: “As healthcare systems face continued pressure to deliver improved access to care at a lower cost, increased connectivity between HCPs and patients becomes even more important.

“This innovative technology continues the CoaguChek legacy of setting the standard in coagulation monitoring by providing high quality, convenient care, while optimising outcomes for patients. This is another proof point towards our aim to position patient self-testing as the standard of care to monitor VKA therapy.”

The company says CoaguChek INRange is the first Bluetooth-enabled device of its kind device for prothrombin time PT (INR) home self-testing for remote care programmes for anticoagulated patients.

Frequent self-testing has been shown to keep patients who adhere to their monitoring therapy within their therapeutic range, with consequent lower risks of stroke or bleeding.

The device's launch comes shortly after Roche picked up some marketing rights to a new implantable diabetes monitor. It will distribute Senseonics' Eversense implantable long-term continuous glucose monitoring in Germany, Italy and the Netherlands.

7th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics